key: cord-0867261-hqtwaad0
authors: AKIYOSHI, Makoto; HISASUE, Masaharu; NEO, Sakurako; AKIYOSHI, Masami
title: Presumptive precursor-targeted immune-mediated anemia concurrent with gastrointestinal lymphoma in a cat
date: 2020-08-28
journal: J Vet Med Sci
DOI: 10.1292/jvms.20-0386
sha: 8b556690c55265541919caa3cdd5c9812e69de67
doc_id: 867261
cord_uid: hqtwaad0

A 10-year-old spayed female mixed-breed cat presented with progressive nonregenerative anemia. Clinicopathological abnormalities included severe nonregenerative anemia (packed cell volume [PCV]: 7%, aggregate reticulocytes: 1.12 × 10(3)/µl) and a hypoechogenic mass well-localized in the stomach. Bone marrow (BM) smears revealed increased particle hematopoietic cellularity with decreased myeloid:erythroid (M:E) ratios, no dysplasia of any lineage, and presence of erythroid precursors phagocytized by macrophages. The cat was diagnosed with presumptive precursor-targeted immune-mediated anemia (PIMA). The stomach mass was consistent with CD 20 positive T-cell lymphoma. The lymphoma was completely resected via surgery, and the PIMA was cured by immunosuppressive therapy. On day 410, both diseases have not recurred without medications. This is the first report of feline PIMA and concurrent gastrointestinal lymphoma.

not resolve the hematological abnormalities.

On presentation, physical examination revealed a fever (41°C) and pale oral mucosa. CBC results (IDEXX ProCyte Dx Hematology Analyzer; IDEXX Laboratories, Tokyo, Japan) revealed a severe, normocytic, normochromic, nonregenerative anemia (PCV: 7%; mean cell volume (MCV): 39.1 fl, MCHC, mean corpuscular hemoglobin concentration (MCHC): 32.9 d/dl). The aggregates reticulocyte concentrations were counted by manual procedure using NMB stain. The aggregate reticulocyte concentrations were 1.12 × 10 3 /µl (Table  1) . A routine plasma biochemistry (FUJIFILM DRI-CHEM 7000V; FUJIFILM Co., Tokyo, Japan) revealed no abnormalities; however, the serum amyloid A (SAA) was severely increased (Table 1) . Serologic tests were negative for the feline leukemia virus (FeLV) antigen and the feline immunodeficiency virus (FIV) antibody (SNAP, FeLV/FIV Combo, IDEXX Laboratories, Tokyo, Japan). The serologic test for feline pancreatic lipase immunoreactivity (f-PLI) was normal (SNAP, f-PLI Kit, IDEXX Laboratories). Feline infectious peritonitis (FIP) was less likely because the serum antibody value was negative for the feline coronavirus (FCoV) (immunofluorescence assay method, IDEXX Laboratories). Systemic radiographs, urinalysis and a fecal examination were normal. No melena was observed. Ultrasonography revealed evidence of a hypoechogenic mass (2.2 × 1.9 cm) well-localized in the stomach (Fig. 1) , an enlarged regional lymph node (1.7 × 0.8 cm) and no abnormalities in the other abdominal organs. Direct Coombs test and saline slide agglutination tests at room temperature and at 4°C were performed at a commercial laboratory (FUJIFILM VET Systems, Tokyo, Japan), and they revealed a negative result. Hemostatic tests were no abnormalities (Table 1) . Serum iron, total iron-binding capacity (TIBC), unsaturated iron-binding capacity (UIBC), folate, vitamin B 12, and erythropoietin (EPO) were examined at a commercial laboratory. Systemic hemorrhaging including gastrointestinal was unlikely because of the increased serum iron concentrations (198 µg/dl), decreased serum UIBC concentrations (12 µg/dl) and the normal plasma total protein and albumin concentrations (Table 1) . Serum TIBC, folate, vitamin B 12 , and EPO concentrations were within their normal range of RIs (Table 1) . The blood culture examination was negative. Infections with Anaplasma spp, Bartonella spp, Cytauxzoon felis, Ehrlichia spp, feline Haemoplasma, FeLV, FIV, and FCoV were ruled out via real-time PCR, which was performed on the peripheral blood at a commercial laboratory (IDEXX Laboratories). No exposure to oxidative toxins was evidenced.

On day 1, the cat received whole blood transfusion (20 ml/kg BW, total: 76 ml). On the following day, bone marrow (BM) was aspirated at three sites, including the bilateral proximal humerus and proximal femur, and the cat underwent extirpation of the masses in the stomach and regional lymph node (Fig. 2) . The stomach mass was removed surgically in the horizontal margin 2 cm and 2 cm part of the omentums in addition to all layer of the stomach in the deep margin.

A 500-cell differential cell counts were performed on each of three BM aspiration smears. The count included mature neutrophils. BM cellularity was high with normal numbers of mature megakaryocytes (5-6 cells per ×100 magnification) [14, 23] . Nine marrow particles and all the particles demonstrated moderate numbers of hemosiderin-laden macrophages, indicating adequate iron stores in this cat [5, 15] . No morphological abnormalities were seen. The myeloid: erythroid (M:E) ratio was low at 0.35:1 (0.35; RI, 1.2-2.2) (Fig. 3 ). Erythroid series maturation was complete with a moderate left shift characterized by increased rubricytes and prorubricytes. Myeloid series maturation was complete, balanced, and morphologically unremarkable. Polychromatophils were very few observed in the background. Lymphocytes and plasmacytes were within the reference intervals (RI) at 11.3% and 1.5%, respectively [14, 15] . Macrophages occasionally contained phagocytized intact erythroid precursors (Fig. 3) . No infectious agents were seen. The real-time PCR of FeLV provirus performed on BM aspiration samples was negative. The cat was diagnosed with presumptive precursor immunemediated anemia (PIMA). Histologic sections of the gastric mass and gastric lymph node were routinely prepared and examined. Expanding the submucosa and tunica muscularis, several neoplastic tissues proliferated in an individual-to-confluent manner and exhibited coalescing foci (Fig. 4) . Each tissue was composed of sheets of slightly atypical round cells with scant eosinophilic cytoplasm, round-to-ovoid hypochromatic nuclei approximately twice the size of a red blood cell, and distinct nucleoli (Fig. 4) . The mitotic count was 30 per ten 400× fields. Neoplastic cells resembling centroblasts were infrequently observed (less than 5 per one 400× field). Rarely, neoplastic cells were observed adjacent to the stomach serosa but without breaching it (Fig. 4) . No neoplastic invasion was noticed in the blood or lymph vessels. The overlying mucosa was rimmed by hyperplastic, but not neoplastic, mucosa. The gastric mass was diagnosed as transmural lymphoma with large cell types. The surgical margins were achieved completely. The GI lymphoma was completely resected. The gastric lymph node showed no neoplastic changes and was diagnosed with reactive lymph node. Based on these findings, the GI lymphoma was definitively well-localized in the stomach. Immunohistochemical staining was performed for CD3, CD20, and granzyme B using a mouse anti-CD3 monoclonal antibody (1-2 µg/ml; Clone, F7.2.38; Thermo Fisher Scientific, Waltham, MA, USA), rabbit anti-CD20 polyclonal antibody (0.1-0.5 µg/ml; Thermo Fisher Scientific), and rabbit anti-granzyme B polyclonal antibody (1:100-400 dilution; Spring Bioscience, Pleasanton, CA, USA), respectively. The gastric mass tumor cells reacted strongly to the anti-CD20 antibody and weakly to the anti-CD3 antibody, while no reaction occurred against anti-granzyme B antibodies (Fig. 4) . PCR for antigen receptor gene rearrangement (PARR) analysis (Kahotechno Co., Ltd., Fukuoka, Japan) was performed to examine clonal lymphocyte expansion in the GI lymphoma, the reactive lymph node and BM smears. As previously described, genomic DNA was extracted from the GI lymphoma tissue, the lymph node tissue and BM smears [1, 9, 10] . Clonal rearrangements of the T-cell receptor γ (TCRγ) gene were detected on the GI lymphoma only (Fig. 5) . No clonal patterns were detected for the immunoglobulin heavy-chain (IgH) gene rearrangement on all samples. The primers and amplification design were based on the previous reports [13, 24] . The GI lymphoma was CD20 positive T-cell lymphoma with transmural morphology. Consequently, the cat was diagnosed with presumptive PIMA concurrent with primary GI lymphoma. Prednisolone (4 mg/kg, PO, q24 hr) as immunosuppressive therapy and enrofloxacin (8 mg/kg, PO, q24 hr) as the infection prevention after the surgery were administered on day 2 (Fig.  6) . The enrofloxacin was stopped on day 16. Chlorambucil (2 mg head, PO, every other day) as immunosuppressive and anti-cancer therapy was administered on day 10 (Fig. 5) . On day 30, the anemia and increased SAA were resolved (PCV: 27%, RBCs: 6.65 × 10 6 /µl, aggregate reticulocyte concentrations: 19.5 × 10 3 /µl; and SAA: 1.2 µg/ml) (Fig. 5) . PIMA and GI lymphoma did not recur as the prednisolone and chlorambucil were tapered every 2-4 weeks. On day 410, the cat was in good condition without the medications (Fig. 6) . The recurrence of PIMA has not been seen and the ultrasonography showed no evidence of GI lymphoma. This is the first report of a presumptive feline PIMA with definitely T-cell GI lymphoma well-localized in the stomach. PIMA is considered a separate entity within a spectrum of IMHA and is characterized by selective targeting erythroid precursors in the BM [2, 8, 23] . Few reports have been published on canine PIMA, and feline case has not been reported [2, 8, 23] . Therefore, feline PIMA requires further characterization including cause, clinicopathological finding, therapeutic protocol and prognosis. In this disorder, rubriphagocytosis characterized by phagocytosis of intact erythroid precursors is usually seen in PIMA cases but is nonpathognomonic for this disease [2, 8] . The previous study to characterize canine PIMA characterized it by 1) persistent nonregenerative anemia, 2) ineffective erythropoiesis, and 3) absence of dysplasia of any lineage [2, 8] . Nonregenerative anemia in cats is defined as PCV <20% with aggregate reticulocyte count <15 × 10 3 /µl by some previous reports [3, 17, 25] . The present case showed persistent nonregenerative anemia without the presence of aggregate reticulocytosis. Generally, ineffective erythropoiesis is defined as persistent nonregenerative anemia accompanied by increased particles hematopoietic cellularity with decreased M:E ratios in BM and an absence of aggregate reticulocytosis [2, 3, 8, 25] . The cat in the present study had increased cellularity with decreased M:E ratios in the BM and persistent nonregenerative anemia without the presence of aggregate reticulocytosis in peripheral blood. The cat had definitive ineffective erythropoiesis. As other differentiate diagnosis of ineffective erythropoiesis, there are FeLV infection, iron deficiency including gastrointestinal hemorrhage, myelodysplastic syndrome (MDS), BM involvement by neoplastic tumor, and, rarely, folate or cobalamin deficiency [14, 15] . The latter two were excluded out in this cat. FeLV infection was excluded by negative of antigen detection serology, and real-time PCR in the peripheral blood and BM samples, respectively. Gastrointestinal hemorrhage was unlikely since plasma total protein and albumin concentrations were normal range, and clinical signs also were not seen. Iron deficiency was ruled out by increased serum iron concentration, decreased serum UIBC concentration, and presence of numerous BM hemosiderin-containing macrophages, indicating that the BM iron stores were adequate. It is reported that healthy cats lack detectable marrow iron stores, but adequate BM iron stores in cat having immunemediated anemia (IMA) including IMHA and PIMA are present [15, 17] . We believe that the increased serum iron concentration and decreased UIBC concentration resulted from the PIMA and indicate ineffective BM erythropoiesis in this cat. The present case lacked dysplasia of any lineage and MDS was excluded. Histiocytic diseases including histiocytic sarcoma and hemophagocytic syndrome were excluded based on the absence of malignant findings and a cut-off of <2% hemophagocytic histiocytes [22] . The lymphocytes and plasmacytes in the BM were within the RI [14, 15] . However, PARR was performed and negative in the BM; thus, BM lymphoid neoplasia was excluded. As a result, the present case was diagnosed with presumptive PIMA.

In previous literature, GI lymphomas were classified as B-cell, T-cell, non-B-cell, or non-T-cell lymphomas by immunohistochemistry to detect CD3 and CD79a or CD20 expressions [11, 12, 18, 26, 27] . These GI lymphomas were then further classified as mucosal or transmural lymphomas [12, 26, 27] . The present case was diagnosed as transmural lymphoma with infiltration of large lymphocytes. Feline transmural lymphomas were reported as diffuse large cell B-cell lymphoma (DLBCL), enteropathy-associated T-cell lymphoma (EATCL) type I with/without LGL lymphocytes morphology [12] . This cat was diagnosed with transmural T-cell lymphoma well-localized in the stomach without LGL morphology, because no reaction occurred against anti-granzyme B antibodies and clonal patterns for the TCRγ gene were positive, and IgH gene was negative. In addition, the present lymphoma was CD20 positive T-cell lymphoma by detection of clonal patterns for the TCRγ gene, although the GI lymphoma reacted to both the anti-CD20 antibody (strongly positive) and anti-CD3 antibody (weakly positive). Rarely, it is difficult to made lymphoma classification based on only the result of immunohistochemistry in other species since CD20 positive T-cell lymphoma of GI lymphoma has been reported in humans and dogs [6, 16] . Some studies described that activated T-cell lymphoma was likely reacted to anti-CD20 antibody [6, 16] . The GI T-cell lymphoma of present cat was double-positive in CD20 and CD3.

The present case had good prognosis by combination of complete surgical resection, prednisolone and chlorambucil. The majority of transmural lymphomas in stomach are known as diffuse, large B-cell lymphomas (DLBCL) characterized by centroblastic type and high mitotic rate, and thus have poor prognosis (median survival time: 3.5months) [12] . However, the present case was not DLBCL but CD20 positive T-cell lymphoma with transmural high-grade morphology and has been having long prognosis. The prognosis of feline CD20 positive T-cell lymphoma in stomach is unknown. However, we consider that aggressive resection of discrete GI lymphoma well-localized in the stomach may be a reasonable consideration, even if the GI lymphoma is expected as high-grade lymphoma. The two latest studies reported that feline discrete intermediate-or large-cell GI lymphoma with complete surgical margins may survive longer than with incomplete margin or without surgical lymphoma masses resection [4, 20] . Probably, complete surgical margins in this case contribute to have good prognosis.

Secondary PIMA may result from several causes such as neoplasia, infectious diseases, and inflammatory diseases. The SAA, like C-reactive protein, is an acute-phase protein. Increased serum SAA levels are triggered by physical injury to the host, including infectious diseases, inflammatory diseases and neoplasia [19] . In our case, many infections were most likely ruled out based on PCRs and bacterial culture of the blood. Inflammatory diseases, including cholangitis and pancreatitis, were less likely in the present case, because the liver enzymes and f-PLI were within the reference intervals; therefore, the cause of the increased SAA was considered GI lymphoma. We considered that the present case was not differentiated secondary to lymphoma or primary because there is no reliable test to differentiate between the 2 pathogenesis in veterinary medicine. Therefore, the presence of concurrent GI lymphoma and PIMA in our case may represent two comorbidities rather than PIMA secondary to GI lymphoma.

In the previous report, some lymphomas have been suspected to be likely associated with the occurrence of IMA, such as IMHA [17] . IMHA involves the immune system targeting mature RBCs, which results in hemolysis, and is often accompanied by spherocytes, agglutination, or Coombs' positivity. Swann et al. reported that primary IMHA occurred more commonly than secondary and nonregenerative anemia were seen in 25.4% (16/63) and 29.6% (8/27) in primary and secondary IMHA, respectively [17] . Furthermore, erythrophagocytosis in BM was seen in 40% (26/65) with IMHA, and some cats showed erythroid precursors phagocytosis by macrophage [17] . We consider some of those IMHA cases with nonregenerative anemia actually must be PIMA. The numbers of cats diagnosed as PIMA will increase by definitive cytological BM examination, further study will be needed in future.

To the best of our knowledge, this is the first report of concurrent with feline PIMA and GI lymphoma. This case represents a potential novel information for PIMA with GI lymphoma in cats, which resolved following immunosuppressive therapy that includes anti-cancer efficiency and completely resection of lymphoma. Further cases may be identified with BM aspiration on GI lymphoma, particularly in nonregenerative anemia. Further clinical study and more data are required to clarify a causal link between PIMA and GI lymphoma.

A case of hemophagocytic syndrome progressing into large granular lymphoma in a dog

Clinical features of precursor-targeted immunemediated anemia in dogs: 66 cases

Feline non-regenerative immune-mediated anaemia: features and outcome in 15 cases

Feline discrete high-grade gastrointestinal lymphoma treated with surgical resection and adjuvant CHOP-based chemotherapy: retrospective study of 20 cases

How should stainable iron in bone marrow films be assessed?

CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review

Primary immune-mediated hemolytic anemia in 19 cats: diagnosis, therapy, and outcome (1998-2004)

Histologic and cytologic bone marrow findings in dogs with suspected precursor-targeted immune-mediated anemia and associated phagocytosis of erythroid precursors

Multiplex PCR and Genescan analysis to detect immunoglobulin heavy chain gene rearrangement in feline B-cell neoplasms

GeneScan analysis to detect clonality of T-cell receptor γ gene rearrangement in feline lymphoid neoplasms

Extranodal lymphoma in the cat: prognostic factors and treatment options

Feline gastrointestinal lymphoma: mucosal architecture, immunophenotype, and molecular clonality

Characterization of feline T cell receptor gamma (TCRG) variable region genes for the molecular diagnosis of feline intestinal T cell lymphoma

Normal hematology of the cat

Bone marrow and lymph node

Concurrent with T-zone lymphoma and high-grade gastrointestinal cytotoxic T-cell lymphoma in a dog

Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia

WHO classification of tumors of haematopoietic and lymphoid tissues. World Health Organization

Serum amyloid A as a prognostic marker in cats with various diseases

Outcomes in 40 cats with discrete intermediate-or largecell gastrointestinal lymphoma masses treated with surgical mass resection

Differentiating benign and malignant causes of lymphocytosis in feline bone marrow

Hemophagocytic syndrome in dogs: 24 cases

Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia and pure red cell aplasia

Characterization of feline immunoglobulin heavy chain variable region genes for the molecular diagnosis of B-cell neoplasia

Feline non-regenerative anemia: Diagnostic and treatment recommendations

Does categorisation of lymphoma subtypes according to the World Health Organization classification predict clinical outcome in cats?

World Health Organisation classification of lymphoid tumours in veterinary and human medicine: a comparative evaluation of gastrointestinal lymphomas in 61 cats

ACKNOWLEDGMENTS. We would like to thank Yoshiharu Ohsato (Kahotechno Co., Ltd., Fukuoka Japan) for the offer and advice of the PARR data. We would like to thank No-boundaries Animal Pathology for advice of the histological findings. We would also like to thank the veterinary nurses of Akiyoshi Animal Clinic for their involvement in this case.